Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 635
Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 239
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 134
Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review
Uttpal Anand, Champa Keeya Tudu, Samapika Nandy, et al.
Journal of Ethnopharmacology (2021) Vol. 284, pp. 114744-114744
Open Access | Times Cited: 111
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 83
Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective
Uttpal Anand, María Carpena, Monika Kowalska‐Góralska, et al.
The Science of The Total Environment (2022) Vol. 821, pp. 153472-153472
Open Access | Times Cited: 77
Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives
Sicon Mitra, Uttpal Anand, Niraj Kumar Jha, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 71
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 68
A novel electrospun nanofiber system with PEGylated paclitaxel nanocrystals enhancing the transmucus permeability and in situ retention for an efficient cervicovaginal cancer therapy
Huan Duan, Haini Chen, Chenrui Qi, et al.
International Journal of Pharmaceutics (2023) Vol. 650, pp. 123660-123660
Closed Access | Times Cited: 44
Strategies and Lessons Learned from Total Synthesis of Taxol
Long Min, Jing‐Chun Han, Wen Zhang, et al.
Chemical Reviews (2023) Vol. 123, Iss. 8, pp. 4934-4971
Closed Access | Times Cited: 43
Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101042-101042
Open Access | Times Cited: 29
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 17
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100770-100770
Closed Access | Times Cited: 93
Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100778-100778
Open Access | Times Cited: 76
Asymmetric Total Synthesis of Taxol
Ya‐Jian Hu, Chen‐Chen Gu, Xin‐Feng Wang, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 42, pp. 17862-17870
Closed Access | Times Cited: 71
Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
Kimberley M. Hanssen, Michelle Haber, Jamie I. Fletcher
Drug Resistance Updates (2021) Vol. 59, pp. 100795-100795
Closed Access | Times Cited: 68
Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer
Qiaoqi Chen, Liang Zhang, Lin Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 61
Betelvine (Piper betleL.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes
Protha Biswas, Uttpal Anand, Suchismita Chatterjee Saha, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 11, pp. 3083-3119
Open Access | Times Cited: 61
Cellular landscaping of cisplatin resistance in cervical cancer
Rahul Bhattacharjee, Tanima Dey, Lamha Kumar, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113345-113345
Open Access | Times Cited: 51
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 49
Paclitaxel resistance related to nuclear envelope structural sturdiness
Elizabeth R. Smith, Jing‐Quan Wang, Dong‐Hua Yang, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100881-100881
Closed Access | Times Cited: 46
RETRACTED: Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model
Vikas Vikas, Abhishesh Kumar Mehata, Medapati Nikitha Lakshmi Suseela, et al.
International Journal of Biological Macromolecules (2022) Vol. 221, pp. 874-890
Closed Access | Times Cited: 37
Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate
Uttpal Anand, Anustup Bandyopadhyay, Niraj Kumar Jha, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 251-269
Open Access | Times Cited: 37
Nano‐biotechnology in tumour and cancerous disease: A perspective review
Ambikesh Soni, Manohar Prasad Bhandari, Gagan Kant Tripathi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 6, pp. 737-762
Open Access | Times Cited: 32
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer
Yuqing Zou, Shuling Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 539-567
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top